Quillivant XR, methylphenidate

General Information

Company	Tris Pharma Inc.
Description	Once-daily, extended-release liquid methylphenidate developed using OralXRplus technology
Molecular Target
Mechanism of Action

Latest Stage of Development	Approved
Indication	Attention deficit hyperactivity disorder (ADHD)
Partner

Product Details

Archive Items are loading